Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...

Elon Musk's SpaceX may be igniting global headlines with the company's astronomical IPO, but biotech listings saw their own record-breaker this week. Parabilis Medicines secured $670 million when it ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

(Beyond Pesticides, May 31, 2024) Among the many promises that have been made by agribusiness to farmers and consumers, the glories of crops genetically engineered (GE) to resist pests stand out. GE ...

Barcelona is famous for its architectural wonders, from the ornate spires of the Sagrada Família to the mosaics of Park Güell. Beyond its rich cultural heritage, the city is building a reputation as a ...

The move adds to a growing list of high-profile transactions over the past decade by U.S. pharmaceutical companies to acquire promising therapies in ‌fields ranging from oncology and neurology to rare ...

Discover the latest in biotechnology with press releases highlighting innovations, research, and developments driving biotech's future. Stay informed on advancements changing biotech and explore ...